Table of Contents Author Guidelines Submit a Manuscript
Autoimmune Diseases
Volume 2015 (2015), Article ID 196537, 5 pages
http://dx.doi.org/10.1155/2015/196537
Review Article

Immunological Parameters Associated With Vitiligo Treatments: A Literature Review Based on Clinical Studies

1Faculdade de Ciências Humanas, Sociais e da Saúde, Universidade Fumec, 30310-190 Belo Horizonte, MG, Brazil
2Departamento de Dermatologia, Santa Casa de Belo Horizonte, 30150-221 Belo Horizonte, MG, Brazil
3Clínica de Dermatologia, Edificio Life Center, 30110-921 Belo Horizonte, MG, Brazil

Received 28 June 2015; Accepted 26 August 2015

Academic Editor: Corrado Betterle

Copyright © 2015 Ana Cláudia Guimarães Abreu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. S. Bellet and N. S. Prose, “Vitiligo in children: a review of classification, hypotheses of pathogenesis and treatment,” Anais Brasileiros de Dermatologia, vol. 80, no. 6, pp. 631–636, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. R. Czajkowski and K. Męcińska-Jundziłł, “Current aspects of vitiligo genetics,” Dermatology and Allergology, vol. 31, no. 4, pp. 247–255, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. M. E. Whiton, M. Pinart, J. Batchelor et al., “Interventions for vitiligo,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003263, 2015. View at Publisher · View at Google Scholar
  4. K. Ezzedine, V. Eleftheriadou, M. Whitton, and N. van Geel, “Vitiligo,” The Lancet, vol. 386, no. 9988, pp. 74–84, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Schmid-Ott, H.-W. Künsebeck, E. Jecht et al., “Stigmatization experience, coping and sense of coherence in vitiligo patients,” Journal of the European Academy of Dermatology & Venereology, vol. 21, no. 4, pp. 456–461, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Krüger and K. Schallreuter, “Stigmatisation, avoidance behaviour and difficulties in coping are common among adult patients with vitiligo,” Acta Dermato Venereologica, vol. 95, no. 5, pp. 553–558, 2015. View at Publisher · View at Google Scholar
  7. A. R. Faria, M. T. Mira, R. G. Tarlé, C. C. Silva de Castro, and G. Dellatorre, “Vitiligo—part 2—classification, histopathology and treatment,” Anais Brasileiros de Dermatologia, vol. 89, no. 5, pp. 784–790, 2014. View at Publisher · View at Google Scholar · View at Scopus
  8. G. F. Mohammed, A. H. A. Gomaa, and M. S. Al-Dhubaibi, “Highlights in pathogenesis of vitiligo,” World Journal of Clinical Cases, vol. 3, no. 3, pp. 221–230, 2015. View at Publisher · View at Google Scholar
  9. K. U. Schallreuter, P. Bahadoran, M. Picardo et al., “Vitiligo pathogenesis: autoimmune disease, genetic defect, excessive reactive oxygen species, calcium imbalance, or what else?” Experimental Dermatology, vol. 17, no. 2, pp. 139–140, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Richmond, M. L. Frisoli, and J. E. Harris, “Innate immune mechanisms in vitiligo: danger from within,” Current Opinion in Immunology, vol. 25, no. 6, pp. 676–682, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Ezzedine, A. Mahé, N. van Geel et al., “Hypochromic vitiligo: delineation of a new entity,” British Journal of Dermatology, vol. 173, no. 3, pp. 716–721, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. R. A. Spritz, “Modern vitiligo genetics sheds new light on an ancient disease,” Journal of Dermatology, vol. 40, no. 5, pp. 310–318, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Speeckaert, M. M. Speeckaert, and N. van Geel, “Why treatments do(n't) work in vitiligo: an autoinflammatory perspective,” Autoimmunity Reviews, vol. 14, no. 4, pp. 332–340, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Picardo and E. Bastonini, “A new view of vitiligo: looking at normal-appearing skin,” Journal of Investigative Dermatology, vol. 135, no. 7, pp. 1713–1714, 2015. View at Publisher · View at Google Scholar
  15. S. Li, G. Zhu, Y. Yang et al., “Oxidative stress-induced chemokine production mediates CD8+ T cell skin trafficking in vitiligo,” Journal of Investigative Dermatology Symposium Proceedings, vol. 17, no. 1, pp. 32–33, 2015. View at Publisher · View at Google Scholar
  16. G. Güntaş, B. Engin, Ö. B. Ekmekçi et al., “Evaluation of advanced oxidation protein products, prooxidant-antioxidant balance, and total antioxidant capacity in untreated vitiligo patients,” Annals of Dermatology, vol. 27, no. 2, pp. 178–183, 2015. View at Publisher · View at Google Scholar
  17. E. H. Kemp, S. Emhemad, S. Akhtar, P. F. Watson, D. J. Gawkrodger, and A. P. Weetman, “Autoantibodies against tyrosine hydroxylase in patients with non-segmental (generalised) vitiligo,” Experimental Dermatology, vol. 20, no. 1, pp. 35–40, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. V. Ingordo, C. Gentile, S. S. Iannazzone, F. Cusano, and L. Naldi, “Vitiligo and autoimmunity: an epidemiological study in a representative sample of young Italian males,” Journal of the European Academy of Dermatology and Venereology, vol. 25, no. 1, pp. 105–109, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. N. A. C. van Geel, I. G. Mollet, S. De Schepper et al., “First histopathological and immunophenotypic analysis of early dynamic events in a patient with segmental vitiligo associated with halo nevi,” Pigment Cell and Melanoma Research, vol. 23, no. 3, pp. 375–384, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. R. M. Luiten, J. G. van den Boorn, D. Konijnenberg et al., “Autoimmune destruction of skin melanocytes by perilesional T cells from vitiligo patients,” Journal of Investigative Dermatology, vol. 129, no. 9, pp. 2220–2232, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. Oiso, T. Suzuki, K. Fukai, I. Katayama, and A. Kawada, “Nonsegmental vitiligo and autoimmune mechanism,” Dermatology Research and Practice, vol. 2011, Article ID 518090, 7 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. Z. A. Taher, G. Lauzon, S. Maguiness, and M. T. Dytoc, “Analysis of interleukin-10 levels in lesions of vitiligo following treatment with topical tacrolimus,” British Journal of Dermatology, vol. 161, no. 3, pp. 654–659, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. Y. H. Jang, S.-E. Jung, J. Shin, and H. Y. Kang, “Triple combination of systemic corticosteroids, excimer laser, and topical tacrolimus in the treatment of recently developed localized vitiligo,” Annals of Dermatology, vol. 27, no. 1, pp. 104–107, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. A. Budania, D. Parsad, A. J. Kanwar, and S. Dogra, “Comparison between autologous noncultured epidermal cell suspension and suction blister epidermal grafting in stable vitiligo: a randomized study,” British Journal of Dermatology, vol. 167, no. 6, pp. 1295–1301, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. V. M. Sheth, S. D. Currimbhoy, H. J. Feetham et al., “Efficacy of narrowband ultraviolet B versus excimer radiation in repigmenting vitiligo after minigrafting on the distal arms,” Journal of the American Academy of Dermatology, vol. 67, no. 2, pp. 318–320, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. S. V. Mulekar, A. Al Issa, and A. Al Eisa, “Treatment of vitiligo on difficult-to-treat sites using autologous noncultured cellular grafting,” Dermatologic Surgery, vol. 35, no. 1, pp. 66–71, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. S. V. Mulekar, A. Al Eisa, M. B. Delvi, A. Al Issa, and A. H. Al Saeed, “Childhood vitiligo: a long-term study of localized vitiligo treated by noncultured cellular grafting,” Pediatric Dermatology, vol. 27, no. 2, pp. 132–136, 2010. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Komen, C. Vrijman, E. P. Tjin et al., “Autologous cell suspension transplantation using a cell extraction device in segmental vitiligo and piebaldism patients: a randomized controlled pilot study,” Journal of the American Academy of Dermatology, vol. 73, no. 1, pp. 170–172, 2015. View at Publisher · View at Google Scholar
  29. M. G. Ramos, D. G. Ramos, G. Gontijo, C. G. Ramos, T. N. Rocha, and R. H. Rocha, “Non-cultured melanocyte/keratinocyte transplantation for the treatment of stable vitiligo on the face: report of two cases,” Anais Brasileiros de Dermatologia, vol. 88, no. 5, pp. 811–813, 2013. View at Publisher · View at Google Scholar · View at Scopus
  30. A. Rao, S. Gupta, A. K. Dinda et al., “Study of clinical, biochemical and immunological factors determining stability of disease in patients with generalized vitiligo undergoing melanocyte transplantation,” British Journal of Dermatology, vol. 166, no. 6, pp. 1230–1236, 2012. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Abdallah, M. B. Abdel-Naser, M. H. Moussa, C. Assaf, and C. E. Orfanos, “Sequential immunohistochemical study of depigmenting and repigmenting minigrafts in vitiligo,” European Journal of Dermatology, vol. 13, no. 6, pp. 548–552, 2003. View at Google Scholar · View at Scopus
  32. M.-N. Zhou, Z.-Q. Zhang, J.-L. Wu et al., “Dermal mesenchymal stem cells (DMSCs) inhibit skin-homing CD8+ T cell activity, a determining factor of vitiligo patients’ autologous melanocytes transplantation efficiency,” PLoS ONE, vol. 8, no. 4, Article ID e60254, 10 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. E. Reyes, P. Jaén, E. D. L. Heras et al., “Systemic immunomodulatory effects of Polypodium leucotomos as an adjuvant to PUVA therapy in generalized vitiligo: a pilot study,” Journal of Dermatological Science, vol. 41, no. 3, pp. 213–216, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. D. P. Antelo, A. L. Filgueira, and J. M. T. Cunha, “Reduction of skin-homing cytotoxic T cells (CD8+–CLA+) in patients with vitiligo,” Photodermatology Photoimmunology and Photomedicine, vol. 27, no. 1, pp. 40–44, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. N. Shi, Y. J. Chen, J. Wang, and H. Ni, “Clinical observation on the effect of Zengse Pill in treating patients with vitiligo of qi-stagnancy and blood-stasis syndrome type,” Chinese Journal of Integrative Medicine, vol. 14, no. 4, pp. 303–306, 2008. View at Google Scholar
  36. M. K. Tembhre, V. K. Sharma, A. Sharma, P. Chattopadhyay, and S. Gupta, “T helper and regulatory T cell cytokine profile in active, stable and narrow band ultraviolet B treated generalized vitiligo,” Clinica Chimica Acta, vol. 424, pp. 27–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  37. N. H. Moftah, R. A. H. El-Barbary, M. A. Ismail, and N. A. M. Ali, “Effect of narrow band-ultraviolet B on CD4+CD25high FoxP3+T-lymphocytes in the peripheral blood of vitiligo patients,” Photodermatology Photoimmunology and Photomedicine, vol. 30, no. 5, pp. 254–261, 2014. View at Publisher · View at Google Scholar · View at Scopus